Participants across Norfolk and Waveney are now being enrolled in to a first-of-its-kind clinical trial investigating the effectiveness of new oral antiviral treatments for COVID-19 – which can be safely taken at home.
The Platform Adaptive trial of Novel antivirals for early treatment of covid-19 In the Community (PANORAMIC) trial will rapidly assess a range of purpose-designed antiviral treatments which could help clinically vulnerable people with COVID-19 in the community recover sooner, prevent the need for hospital admission and ease the burden on the NHS.
These new antiviral treatments are intended for use in the very early stages of infection, by people in the community with COVID-19 who are at higher risk of complications.
The study is taking place within the OneNorwich practice. Anyone who meets the eligibility criteria can sign-up to take part in the study directly with the central study team.
Individuals can join the study if they are aged 50 and over, or between 18 to 49 years with underlying health conditions that make them clinically more vulnerable. All participants also need to have had a positive COVID-19 test and be within five days of the onset of symptoms.
Patients who meet these criteria can enroll in the trial through the trial website or by contacting the study team directly:
Further information on the trial is available for participants on the panoramic website. Homepage — PANORAMIC (panoramictrial.org)